RU2753864C2 - Лиофилизированные фармацевтические композиции для вагинальной доставки - Google Patents

Лиофилизированные фармацевтические композиции для вагинальной доставки Download PDF

Info

Publication number
RU2753864C2
RU2753864C2 RU2019113770A RU2019113770A RU2753864C2 RU 2753864 C2 RU2753864 C2 RU 2753864C2 RU 2019113770 A RU2019113770 A RU 2019113770A RU 2019113770 A RU2019113770 A RU 2019113770A RU 2753864 C2 RU2753864 C2 RU 2753864C2
Authority
RU
Russia
Prior art keywords
dosage form
vaginal
lyophilized
seconds
solid
Prior art date
Application number
RU2019113770A
Other languages
English (en)
Russian (ru)
Other versions
RU2019113770A3 (fr
RU2019113770A (ru
Inventor
Эмили МАСТО
Лиза ГАРРЕТТ
Ниамх БАРРАТ
Йик Тэн ВОНГ
Розалин Тереза МАКЛАФЛИН
Сьюзан Джеррард БЭНБЕРИ
Original Assignee
Каталент Ю.Кей. Суиндон Зайдис Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Каталент Ю.Кей. Суиндон Зайдис Лимитед filed Critical Каталент Ю.Кей. Суиндон Зайдис Лимитед
Publication of RU2019113770A publication Critical patent/RU2019113770A/ru
Publication of RU2019113770A3 publication Critical patent/RU2019113770A3/ru
Application granted granted Critical
Publication of RU2753864C2 publication Critical patent/RU2753864C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/2036—Silicones; Polysiloxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Virology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RU2019113770A 2016-10-13 2017-10-13 Лиофилизированные фармацевтические композиции для вагинальной доставки RU2753864C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662407709P 2016-10-13 2016-10-13
US62/407,709 2016-10-13
PCT/IB2017/056373 WO2018069888A1 (fr) 2016-10-13 2017-10-13 Compositions pharmaceutiques lyophilisées pour administration vaginale

Publications (3)

Publication Number Publication Date
RU2019113770A RU2019113770A (ru) 2020-11-17
RU2019113770A3 RU2019113770A3 (fr) 2021-01-26
RU2753864C2 true RU2753864C2 (ru) 2021-08-24

Family

ID=60320930

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2019113770A RU2753864C2 (ru) 2016-10-13 2017-10-13 Лиофилизированные фармацевтические композиции для вагинальной доставки

Country Status (9)

Country Link
US (1) US11026883B2 (fr)
EP (1) EP3525765A1 (fr)
JP (1) JP7219712B2 (fr)
CN (1) CN110267652A (fr)
AU (1) AU2017342160A1 (fr)
CA (1) CA3040422A1 (fr)
MX (1) MX2019004238A (fr)
RU (1) RU2753864C2 (fr)
WO (1) WO2018069888A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4368169A3 (fr) 2016-12-31 2024-08-07 Bioxcel Therapeutics, Inc. Utilisation de dexmédétomidine sublinguale permettant le traitement de l'agitation
AU2019295699A1 (en) 2018-06-27 2021-01-28 Arx, Llc Film formulations containing dexmedetomidine and methods of producing them
MX2021004553A (es) * 2018-10-23 2021-07-16 Eastern Virginia Medical School Composiciones farmaceuticas y metodos para fabricar formulaciones de dosificacion solidas bajo demanda.
KR20220049526A (ko) 2019-07-19 2022-04-21 바이오엑셀 테라퓨틱스 인코포레이티드 비-진정성 덱스메데토미딘 치료 양생법
US20240000705A1 (en) * 2020-09-17 2024-01-04 Catalent U.K. Swindon Zydis Limited Use of surfactant with high molecular weight fish gelatin based dosage formulations to improve flow characteristics
US11672761B2 (en) 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans
CN112353933B (zh) * 2020-12-14 2021-09-24 黑龙江中医药大学 一种预防和/或治疗子宫肌瘤的药物及其制备方法
WO2023204734A1 (fr) 2022-04-21 2023-10-26 Общество С Ограниченной Ответственностью "Кинетик-Фарм" Composition pour administration intravaginale de composant actif, et procédé de production et d'utilisation d'agent
CN115656526B (zh) * 2022-12-22 2023-07-04 北京水木济衡生物技术有限公司 糖化血红蛋白质控品的制备方法、复溶装置和复溶剂
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2459620C2 (ru) * 2007-03-30 2012-08-27 Лаккуре Аб Применение олигомеров молочной кислоты в лечении гинекологических расстройств
WO2012151237A1 (fr) * 2011-05-02 2012-11-08 Aptalis Pharmatech, Inc. Compositions de comprimés à dissolution rapide pour administration vaginale
RU2587717C2 (ru) * 2011-01-28 2016-06-20 Пробиотикал С.п.А. Шипучая композиция в твердой форме для применения в вагинальных приложениях для лечения вагинальных инфекций

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1548022A (en) 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
US4642903A (en) 1985-03-26 1987-02-17 R. P. Scherer Corporation Freeze-dried foam dosage form
US5178878A (en) 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
US5417224A (en) * 1993-05-19 1995-05-23 Advanced Medical Instruments, Inc. Tampon and method for manufacturing the same
US5622719A (en) 1993-09-10 1997-04-22 Fuisz Technologies Ltd. Process and apparatus for making rapidly dissolving dosage units and product therefrom
GB9504201D0 (en) 1995-03-02 1995-04-19 Scherer Ltd R P Process for the preparation of a solid pharmaceutical dosage form
US6024981A (en) 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
CA2239199A1 (fr) 1997-06-11 1998-12-11 Eric Segal Moule a confiseries pour micro-ondes et methode d'utilisation
US5976577A (en) 1997-07-11 1999-11-02 Rp Scherer Corporation Process for preparing fast dispersing solid oral dosage form
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
BR0007360A (pt) * 1999-12-23 2001-08-14 Johnson & Johnson Composição de liberação controlada
US6509040B1 (en) 2001-06-22 2003-01-21 R.P. Scherer Corporation Fast dispersing dosage forms essentially free of mammalian gelatin
US20040156894A1 (en) * 2003-02-07 2004-08-12 Grother Leon Paul Use of edible acids in fast-dispersing pharmaceutical solid dosage forms
EP1872775A1 (fr) * 2006-06-29 2008-01-02 Polichem S.A. Emploi d'une matrice hydrophile contenant un dérivé polyacrylique, un éther de cellulose et un désintégrant, pour la production d'un médicament pour le traitement des troubles génitales d'une femme
US9205049B2 (en) * 2008-06-19 2015-12-08 University Of The Witwatersrand, Johannesburg Transmucosal delivery system
EP2174650A1 (fr) * 2008-10-08 2010-04-14 Polichem SA Émulsions à libération modifiée pour une application sur la peau ou la muqueuse vaginale
KR101421330B1 (ko) * 2008-12-17 2014-07-18 사토 세이야쿠 가부시키가이샤 붕괴정
US10548839B2 (en) * 2010-03-16 2020-02-04 Wei Tian Process of manufacturing a lyophilized fast dissolving, multi-phasic dosage form
CN102784120B (zh) 2012-08-23 2014-03-26 海南卫康制药(潜山)有限公司 甲硝唑组合物阴道冻干崩解片及其制备方法
JP6341777B2 (ja) * 2014-06-30 2018-06-13 リプリーズ バイオファーマシューティクス，エルエルシー 低用量デスモプレシンを含有する医薬組成物

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2459620C2 (ru) * 2007-03-30 2012-08-27 Лаккуре Аб Применение олигомеров молочной кислоты в лечении гинекологических расстройств
RU2587717C2 (ru) * 2011-01-28 2016-06-20 Пробиотикал С.п.А. Шипучая композиция в твердой форме для применения в вагинальных приложениях для лечения вагинальных инфекций
WO2012151237A1 (fr) * 2011-05-02 2012-11-08 Aptalis Pharmatech, Inc. Compositions de comprimés à dissolution rapide pour administration vaginale

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ABRUZZO A ET AL., "Chitosan/alginate complexes for vaginal delivery of chlorhexidine digluconate", CARBOHYDRATE POLYMERS, Vol. 91, 2, 2013-01-01, page 651-658, найдено онлайн, найдено в Интернете: https://www.sciencedirect.com/science/article/pii/S0144861712008648?via%3Dihub. *
Luana Perioli et al., New solid mucoadhesive systems for benzydamine vaginal administration, Colloids Surf B Biointerfaces, 2011 Jun 1; 84(2):413-20, найдено онлайн, найдено в Интернете: https://pubmed.ncbi.nlm.nih.gov/21354770/. *
Sandra Borges, Drug delivery systems for vaginal infections, January 2015, In book: Frontiers in clinical drug research: anti-infectives (pp.3-28) Chapter: 3 Publisher: Bentham Science Publishers, найдено онлайн, найдено в Интернете: https://www.researchgate.net/publication/305391874_Drug_delivery_systems_for_vaginal_infections. *
Sandra Borges, Drug delivery systems for vaginal infections, January 2015, In book: Frontiers in clinical drug research: anti-infectives (pp.3-28) Chapter: 3 Publisher: Bentham Science Publishers, найдено онлайн, найдено в Интернете: https://www.researchgate.net/publication/305391874_Drug_delivery_systems_for_vaginal_infections. Luana Perioli et al., New solid mucoadhesive systems for benzydamine vaginal administration, Colloids Surf B Biointerfaces, 2011 Jun 1; 84(2):413-20, найдено онлайн, найдено в Интернете: https://pubmed.ncbi.nlm.nih.gov/21354770/. *

Also Published As

Publication number Publication date
RU2019113770A3 (fr) 2021-01-26
CA3040422A1 (fr) 2018-04-19
JP2019532109A (ja) 2019-11-07
AU2017342160A1 (en) 2019-05-23
US20190314274A1 (en) 2019-10-17
MX2019004238A (es) 2019-11-08
EP3525765A1 (fr) 2019-08-21
RU2019113770A (ru) 2020-11-17
CN110267652A (zh) 2019-09-20
JP7219712B2 (ja) 2023-02-08
WO2018069888A1 (fr) 2018-04-19
US11026883B2 (en) 2021-06-08

Similar Documents

Publication Publication Date Title
RU2753864C2 (ru) Лиофилизированные фармацевтические композиции для вагинальной доставки
Valenta The use of mucoadhesive polymers in vaginal delivery
KR101443149B1 (ko) 여성의 생식기 질환에 대한 치료제로서 폴리아크릴산 유도체, 셀룰로오스 에테르 및 붕해제를 포함하는 친수성 매트트릭스의 용도
AU2004238321B2 (en) Highly plastic granules for making fast melting tablets
JP6174585B2 (ja) 速溶性医薬組成物
ES2751329T3 (es) Proceso de fabricación de una forma de dosificación multifásica de rápida disolución liofilizada
Sahoo et al. Intra vaginal drug delivery system: an overview
Gupta et al. Exploring novel approaches to vaginal drug delivery
JP2019532109A5 (fr)
Valamla et al. Engineering drug delivery systems to overcome the vaginal mucosal barrier: Current understanding and research agenda of mucoadhesive formulations of vaginal delivery
KR20010057581A (ko) 방출이 조절되는 조성물
KR20150085826A (ko) 속방 및 연장-방출형 조성물
Boateng et al. Polysaccharide based formulations for mucosal drug delivery: a review
Dobaria et al. Vaginal drug delivery systems: a review of current status
Lalan et al. Polymers in vaginal drug delivery: Recent advancements
das Neves et al. Vaginal drug delivery
Akdag et al. Evaluation of preparation methods for orally disintegrating tablets
US8663678B2 (en) Solid dosage form for the ocular administration of an active principle, a soluble, solid ophthalmic insert and the production method thereof
Khan et al. A Review-Vaginal Drug Delivery System
CN115054580A (zh) 大规格冻干口腔崩解片
das Neves Vaginal delivery of biopharmaceuticals
US11260024B2 (en) Polymeric compositions containing ambient-temperature stable biopharmaceuticals and methods for formulation thereof
CA2689987A1 (fr) Composition pharmaceutique d'un nouveau systeme destine a la liberation de steroides dans le vagin
Vanić et al. Hydrogels for vaginal drug delivery
Rahman et al. Vaginal drug delivery system a promising approach for antiretroviral drug in the prevention of HIV infection: a review